Müller S - Search Results

1

Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses.

Farin HF, Mosa MH, Ndreshkjana B, Grebbin BM, Ritter B, Menche C, Kennel KB, Ziegler PK, Szabó L, Bollrath J, Rieder D, Michels BE, Kress A, Bozlar M, Darvishi T, Stier S, Kur IM, Bankov K, Kesselring R, Fichtner-Feigl S, Brüne B, Goetze TO, Al-Batran SE, Brandts CH, Bechstein WO, Wild PJ, Weigert A, Müller S, Knapp S, Trajanoski Z, Greten FR. Farin HF, et al. Among authors: muller s. Cancer Discov. 2023 Oct 5;13(10):2192-2211. doi: 10.1158/2159-8290.CD-23-0050. Cancer Discov. 2023. PMID: 37489084 Free PMC article.

2

Out of the box binding determines specificity of SH2 domain interaction.

Müller S, Knapp S. Müller S, et al. Structure. 2009 Aug 12;17(8):1040-1. doi: 10.1016/j.str.2009.07.002. Structure. 2009. PMID: 19679083 Free PMC article.

3

Targeting kinases for the treatment of inflammatory diseases.

Müller S, Knapp S. Müller S, et al. Expert Opin Drug Discov. 2010 Sep;5(9):867-81. doi: 10.1517/17460441.2010.504203. Epub 2010 Jul 15. Expert Opin Drug Discov. 2010. PMID: 22823261

4

The ins and outs of selective kinase inhibitor development.

Müller S, Chaikuad A, Gray NS, Knapp S. Müller S, et al. Nat Chem Biol. 2015 Nov;11(11):818-21. doi: 10.1038/nchembio.1938. Nat Chem Biol. 2015. PMID: 26485069 No abstract available.

5

Epigenomic regulation of oncogenesis by chromatin remodeling.

Kumar R, Li DQ, Müller S, Knapp S. Kumar R, et al. Among authors: muller s. Oncogene. 2016 Aug 25;35(34):4423-36. doi: 10.1038/onc.2015.513. Epub 2016 Jan 25. Oncogene. 2016. PMID: 26804164 Review.

6

Development of Selective CBP/P300 Benzoxazepine Bromodomain Inhibitors.

Popp TA, Tallant C, Rogers C, Fedorov O, Brennan PE, Müller S, Knapp S, Bracher F. Popp TA, et al. Among authors: muller s. J Med Chem. 2016 Oct 13;59(19):8889-8912. doi: 10.1021/acs.jmedchem.6b00774. Epub 2016 Sep 27. J Med Chem. 2016. PMID: 27673482

7

Development, Optimization, and Structure-Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4- d]pyrrolo[2,3- b]pyridine Scaffold.

Forster M, Chaikuad A, Dimitrov T, Döring E, Holstein J, Berger BT, Gehringer M, Ghoreschi K, Müller S, Knapp S, Laufer SA. Forster M, et al. Among authors: muller s. J Med Chem. 2018 Jun 28;61(12):5350-5366. doi: 10.1021/acs.jmedchem.8b00571. Epub 2018 Jun 13. J Med Chem. 2018. PMID: 29852068

8

Image-Based Annotation of Chemogenomic Libraries for Phenotypic Screening.

Tjaden A, Chaikuad A, Kowarz E, Marschalek R, Knapp S, Schröder M, Müller S. Tjaden A, et al. Among authors: muller s. Molecules. 2022 Feb 21;27(4):1439. doi: 10.3390/molecules27041439. Molecules. 2022. PMID: 35209227 Free PMC article.

9

PROTAC degraders as chemical probes for studying target biology and target validation.

Němec V, Schwalm MP, Müller S, Knapp S. Němec V, et al. Among authors: muller s. Chem Soc Rev. 2022 Sep 20;51(18):7971-7993. doi: 10.1039/d2cs00478j. Chem Soc Rev. 2022. PMID: 36004812 Review.

10

High-content live-cell multiplex screen for chemogenomic compound annotation based on nuclear morphology.

Tjaden A, Giessmann RT, Knapp S, Schröder M, Müller S. Tjaden A, et al. Among authors: muller s. STAR Protoc. 2022 Oct 26;3(4):101791. doi: 10.1016/j.xpro.2022.101791. eCollection 2022 Dec 16. STAR Protoc. 2022. PMID: 36317177 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,531 results

Search Page